Zhejiang Orient Gene Biotech Co Ltd (688298) — Tangible Net Worth Ratio
Zhejiang Orient Gene Biotech Co Ltd (688298) has a Tangible Net Worth Ratio of 85.7% as of September 2025. This metric is calculated by deducting intangible assets (CN¥930.15 Million) from net assets (CN¥6.49 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Zhejiang Orient Gene Biotech Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Zhejiang Orient Gene Biotech Co Ltd Tangible Net Worth Ratio (2016–2024)
This chart shows how Zhejiang Orient Gene Biotech Co Ltd's Tangible Net Worth Ratio has changed across 9 annual periods from 2016 to 2024. As of September 2025, the ratio stands at 85.7%, reflecting net assets of CN¥6.49 Billion with intangible assets of CN¥930.15 Million CNY. For live market cap and overall valuation, see market cap of Zhejiang Orient Gene Biotech Co Ltd.
Annual Tangible Net Worth Ratio for Zhejiang Orient Gene Biotech Co Ltd (2016–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Zhejiang Orient Gene Biotech Co Ltd from 2016 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Zhejiang Orient Gene Biotech Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 89.8% | CN¥6.79 Billion | CN¥690.91 Million | CN¥8.09 Billion | ▼ -3.8 pp |
| 2023 | 93.7% | CN¥7.55 Billion | CN¥478.81 Million | CN¥9.00 Billion | ▼ -0.8 pp |
| 2022 | 94.5% | CN¥8.32 Billion | CN¥457.99 Million | CN¥10.70 Billion | ▼ -3.9 pp |
| 2021 | 98.4% | CN¥6.89 Billion | CN¥111.48 Million | CN¥8.98 Billion | ▼ -1.0 pp |
| 2020 | 99.4% | CN¥2.45 Billion | CN¥14.13 Million | CN¥3.57 Billion | ▲ +5.2 pp |
| 2019 | 94.2% | CN¥254.13 Million | CN¥14.62 Million | CN¥361.51 Million | ▼ -1.0 pp |
| 2018 | 95.3% | CN¥208.03 Million | CN¥9.83 Million | CN¥337.65 Million | ▲ +2.5 pp |
| 2017 | 92.8% | CN¥138.12 Million | CN¥9.99 Million | CN¥259.32 Million | ▲ +3.3 pp |
| 2016 | 89.4% | CN¥98.72 Million | CN¥10.43 Million | CN¥241.00 Million | — |